Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction

The aim of the study is to investigate the impact of an initial non-specific / non-cardiac diagnosis on mortality among patients hospitalised with acute myocardial infarction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ST-elevation Myocardial Infarction Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Non ST-elevation Myocardial Infarction Non-ST Elevated Myocardial Infarction Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction Vascular Diseases

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients aged between 18 and 100 years
patients discharged alive with STEMI or NSTEMI

Exclusion criteria

patients who die in hospital
patients not discharged with STEMI or NSTEMI

Treatment and study plan

Primary outcomes

Mortality

Time frame: Mortality censored 1 year after discharged from hospital

Sponsors and collaborators

Lead sponsor

University of Leeds

Other

Collaborators

University College, London

Registry information

Official study title

Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction: A National Cohort Study

Important dates

Study start: 2003
Primary completion: 2013
First posted: Nov 9, 2015
Registry last updated: Nov 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed